PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31542982-11	2020	The pharmacokinetic results indicated that co-administration of GA could increase the systemic exposure of warfarin, including area under the curve (48.87 +- 2.89 microg h mL-1 without GA versus 58.63 +- 1.90 microg h mL-1 with GA), maximum plasma concentration and t1/2.	Glycyrrhetinic Acid	64-66	L1 cell adhesion molecule	Mus musculus	172-176	
31542982-11	2020	The pharmacokinetic results indicated that co-administration of GA could increase the systemic exposure of warfarin, including area under the curve (48.87 +- 2.89 microg h mL-1 without GA versus 58.63 +- 1.90 microg h mL-1 with GA), maximum plasma concentration and t1/2.	Glycyrrhetinic Acid	64-66	L1 cell adhesion molecule	Mus musculus	218-222	
8910850-2	1996	Plasma concentration of glycyrrhetic acid rapidly decreased after its intravenous administration, with AUC of 9200 +/- 1050 ng h mL-1 and MRT of 1.1 +/- 0.2 h. The AUC and MRT values after oral administration were 10600 +/- 1090 ng h mL-1 and 9.3 +/- 0.6 h, respectively.	Glycyrrhetinic Acid	24-41	L1 cell adhesion molecule	Mus musculus	129-148	
8910850-2	1996	Plasma concentration of glycyrrhetic acid rapidly decreased after its intravenous administration, with AUC of 9200 +/- 1050 ng h mL-1 and MRT of 1.1 +/- 0.2 h. The AUC and MRT values after oral administration were 10600 +/- 1090 ng h mL-1 and 9.3 +/- 0.6 h, respectively.	Glycyrrhetinic Acid	24-41	L1 cell adhesion molecule	Mus musculus	234-246